Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels

被引:0
作者
Sonneveld, Milan [1 ]
Chiu, S. M. [2 ]
Park, Jun Yong [3 ]
Kaewdech, Apichat [4 ]
Seto, Wai-Kay [5 ]
Tanaka, Yasuhito [6 ]
Carey, Ivana [7 ]
Papatheodoridi, Margarita [8 ]
van Bommel, Florian [9 ]
Brakenhoff, Sylvia [1 ]
Berg, Thomas [9 ]
Zoulim, Fabien [10 ]
Ahn, Sang Hoon [3 ]
Dalekos, George [11 ]
Erler, Nicole [1 ]
Zu Siederdissen, Christoph Hoener [12 ]
Wedemeyer, Heiner [12 ]
Cornberg, Markus [12 ]
Yuen, Man-Fung [5 ]
Agarwal, Kosh [7 ]
Boonstra, Andre [1 ]
Buti, Maria [13 ]
Piratvisuth, T. [4 ]
Papatheodoridis, George [8 ]
Chen, Chien-Hung [2 ]
Maasoumy, Benjamin [12 ]
机构
[1] Erasmus MC, Rotterdam, Netherlands
[2] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[3] Yonsei Univ, Coll Med, Seoul, South Korea
[4] Prince Songkla Univ, Tambon Kho Hong, Thailand
[5] Univ Hong Kong, Hong Kong, Peoples R China
[6] Kumamoto Univ, Kumamoto, Japan
[7] Kings Coll Hosp London, London, England
[8] Laiko Hosp, Athina, Greece
[9] Univ Hosp Leipzig, Leipzig, Germany
[10] Inserm, Lyon, France
[11] Gen Univ Hosp Larissa, Larisa, Greece
[12] Med Hsch, Hannover, Germany
[13] Hosp Univ Vall dHebron, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT344
引用
收藏
页码:S824 / S825
页数:2
相关论文
共 50 条
  • [31] PREDICTORS OF HBSAG LOSS IN HIV- HBV COINFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY: A SYSTEMATIC REVIEW
    Rahman, Mansoor
    Rehman, F. N. U. Khalil Ur
    Usama, Fatima
    Hassam, Khawaja
    Rasikh, Rohullah
    Shah, Syed Bilal
    Ullah, Ashraf
    Ullah, Zabeeh
    Khan, Abu Baker
    Lau, Daryl
    [J]. HEPATOLOGY, 2024, 80 : S333 - S334
  • [32] HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
    Kim, Gi-Ae
    Lim, Young-Suk
    An, Jihyun
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Suh, Dong Jin
    [J]. GUT, 2014, 63 (08) : 1325 - 1332
  • [33] CHANGES OF HBSAG LEVELS IN PATIENTS WITH EFFECTIVE NUCLEOS(T)IDE ANALOGUE THERAPY - COMPARISON OF DIFFERENT TREATMENT REGIMENS
    Jochum, Christoph
    Thon, Sebastian
    Timm, Joerg
    Roggendorf, Michael
    Canbay, Ali
    Gerken, Guido
    Schlaakl, Joerg F.
    [J]. HEPATOLOGY, 2010, 52 (04) : 531A - 531A
  • [34] Cessation of Nucleos(t)ide Analogue therapy after HBeAg seroconversion does not lead to increased HBsAg loss rates: an international, multi-ethnic cohort study
    Van Hees, Stijn
    Chi, Heng
    Hansen, Bettina E.
    Bourgeois, Stefan
    Van Vlierberghe, Hans
    Serste, Thomas
    Francque, Sven
    Wong, David K.
    Dirk, Sprengers
    Colle, Isabelle
    Moreno, Christophe
    Nevens, Frederik
    Janssen, Harry L.
    Vanwolleghem, Thomas
    [J]. HEPATOLOGY, 2017, 66 : 514A - 514A
  • [35] LOW HBsAg LEVELS MAINTAINED FOLLOWING CESSATION OF THE GALNAC-siRNA, AB-729, IN CHRONIC HEPATITIS B SUBJECTS ON NUCLEOS(T)IDE ANALOGUE THERAPY
    Yuen, Man Fung
    Berliba, Elina
    Sukeepaisarnjaroen, Wattana
    Tangkijvanich, Pisit
    Leerapun, Apinya
    Holmes, Jacinta A.
    Gane, Edward J.
    Jucov, Alina
    Thi, Emily P.
    Sofia, Michael J.
    Sevinsky, Heather
    Eley, Timothy
    Medvedeva, Elina
    Gray, Kevin
    Antoniello, Deana
    Picchio, Gaston R.
    Sims, Karen
    Strasser, Simone I.
    [J]. HEPATOLOGY, 2021, 74 (06) : 1402A - 1403A
  • [36] Reply to: "Probability of HBsAg loss after nucleos(t)ide analogue withdrawal depends on HBV genotype and viral antigen levels"
    Sonneveld, Milan J.
    Chiu, Shao-Ming
    Chen, Chien-Hung
    Maasoumy, Benjamin
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (04) : 1224 - 1226
  • [37] Risk of Hepatocellular Carcinoma after HBsAg Seroclearance Associated with Nucleoside Analogue Therapy in Patients with Chronic Hepatitis B
    Kim, Gi Ae
    Han, Seungbong
    An, Jihyun
    Suh, Dong Jin
    Lim, Young-Suk
    [J]. HEPATOLOGY, 2013, 58 : 629A - 630A
  • [38] Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
    Yao, Chih-Chien
    Hung, Chao-Hung
    Hu, Tsung-Hui
    Lu, Sheng-Nan
    Wang, Jing-Hung
    Lee, Chung-Mo
    Chen, Chien-Hung
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [39] Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
    Chih-Chien Yao
    Chao-Hung Hung
    Tsung-Hui Hu
    Sheng-Nan Lu
    Jing-Hung Wang
    Chung-Mo Lee
    Chien-Hung Chen
    [J]. Scientific Reports, 7
  • [40] RETRACTION: Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment
    Sun, H.
    Liu, Y.
    Zhang, Y.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2024, 2024